[1]
Gooderham, M.J., Kircik, L.H., Zirwas, M., Lee, M., Kempers, S.E., Draelos, Z.D., Ferris, L., Jones, T.M., Saint-Cyr Proulx, E., Bissonnette, R., Bhatia, N., Guenthner, S.T., Koppel, R.A., Welgus, H., Merritt, C., Elias, M., Navale, L., Higham, R.C., Droege, M. and Berk, D.R. 2020. The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s93. DOI:https://doi.org/10.25251/skin.4.supp.93.